N-((Allyloxy)carbonyl)-N-methyl-L-alanine |
| Catalog No.GC66874 |
La N-((Aliloxi)carbonil)-N-metil-L-alanina es un derivado de la alanina. La N-((Aliloxi)carbonil)-N-metil-L-alanina se puede utilizar para la síntesis de inhibidores del factor D del complemento. Los inhibidores del factor D del complemento se pueden utilizar en la investigación de enfermedades relacionadas con el sistema inmunitario.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 918531-01-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
N-((Allyloxy)carbonyl)-N-methyl-L-alanine is a Alanine derivative. N-((Allyloxy)carbonyl)-N-methyl-L-alanine can be used for the synthesis of inhibitors of complement factor D. Complement factor D inhibitors can be used in the research of immune system related disease[1].
[1]. Wiles, Jason Allan, et al. Preparation of pyrimidine-containing compounds for the treatment of Complement factor D - mediated disorders. Patent WO2021168320
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *